At CRISPR Biotech Engineering (CBE), we are an award-winning early-stage genome editing company that is 100% committed to using innovative CRISPR-Cas9 technology to improve human lives and equip students, scientists and researchers with the knowledge to help them understand how the revolutionary technology can transform human life as we know it.


Strategic partnerships are a core component of our chief strategies, empowering us to come up with the resources, knowledge and capabilities to support our research, training and therapeutic programs around CRISPR-Cas9.
If you are a biopharma company, university, academic center, or any other organization that has vested interests in CRISPR-Cas9 technology, please get in touch with us: info@crispr-bte.com